Biosimilars Canada Announces Board Chair and Vice-Chair
Biosimilars Canada is pleased to announce the unanimous election of Mr. Mike Woolcock, Senior Vice President of the Apobiologix division of Apotex, as Chair of the Biosimilars Canada Board. Mr. Mike Casia, President and Managing Director of Organon Canada, has been unanimously elected as Vice-Chair of the Biosimilars Canada Board.